Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients

RATIONALE: Radium-223-Dichloride (Ra-223) is an alpha-emitter, used to treat bone metastases. Patients with high metastatic burden and/or with increased trabecular bone uptake could present a higher incidence of hematologic toxicity. We hypothesized that these two factors are predictors of bone marr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiz, Francesco, Sahbai, Samine, Campi, Cristina, Weissinger, Matthias, Dittmann, Helmut, Marini, Cecilia, Piana, Michele, Sambuceti, Gianmario, la Fougère, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757096/
https://www.ncbi.nlm.nih.gov/pubmed/29435457
http://dx.doi.org/10.1155/2017/3905216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757096/
https://www.ncbi.nlm.nih.gov/pubmed/29435457
http://dx.doi.org/10.1155/2017/3905216

Ejemplares similares